The role of semaphorins in cardiovascular diseases: Potential therapeutic targets and novel biomarkers.

Yin, Zheng; Zhang, Jishou; Xu, Shuwan; Liu, Jianfang; Xu, Yao; Yu, Junping; Zhao, Mengmeng; Pan, Wei; Wang, Menglong; Wan, Jun

Yin, Zheng; Zhang, Jishou; Xu, Shuwan; Liu, Jianfang; Xu, Yao; Yu, Junping; Zhao, Mengmeng; Pan, Wei; Wang, Menglong; Wan, Jun.

Afiliación

Yin Z; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Zhang J; Cardiovascular Research Institute, Wuhan University, Wuhan, China.
Xu S; Hubei Key Laboratory of Cardiology, Wuhan, China.
Liu J; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Xu Y; Cardiovascular Research Institute, Wuhan University, Wuhan, China.
Yu J; Hubei Key Laboratory of Cardiology, Wuhan, China.
Zhao M; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Pan W; Cardiovascular Research Institute, Wuhan University, Wuhan, China.
Wang M; Hubei Key Laboratory of Cardiology, Wuhan, China.
Wan J; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.

FASEB J ; 36(10): e22509, 2022 10.

Article en En | MEDLINE | ID: mdl-36063107

Asunto(s)

Enfermedades Cardiovasculares; Semaforinas; Biomarcadores; Transformación Celular Neoplásica; Humanos; Neovascularización Patológica/patología; Semaforinas/metabolismo

Palabras clave

axonal guidance molecule; cardiovascular diseases; neuropilin; plexin; semaphorin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Semaforinas Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: FASEB J Asunto de la revista: BIOLOGIA / FISIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google